Next Article in Journal / Special Issue
Ethnomedicinal, Phytochemical and Ethnopharmacological Aspects of Four Medicinal Plants of Malvaceae Used in Indian Traditional Medicines: A Review
Previous Article in Journal
Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes
Previous Article in Special Issue
Comparative Evaluation of Oxidative Stress Modulating and DNA Protective Activities of Aqueous and Methanolic Extracts of Acacia catechu
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Scientific Study of Gentiana kurroo Royle

1
Centre of Research for Development (CORD)/Department of Environmental Science, University of Kashmir Srinagar, Srinagar 190006, Jammu and Kashmir (J&K), India
2
Department of Botany, University of Kashmir Srinagar, Srinagar 190006, Jammu and Kashmir (J&K), India
*
Author to whom correspondence should be addressed.
Medicines 2017, 4(4), 74; https://doi.org/10.3390/medicines4040074
Submission received: 9 September 2017 / Revised: 29 September 2017 / Accepted: 30 September 2017 / Published: 12 October 2017
(This article belongs to the Special Issue Herbal Medicines and Functional Foods)

Abstract

:
The present investigation was carried out to review and highlight the potential phytochemicals and medicinal phenomena of the critically endangered medicinal plant, Gentiana kurroo Royle of the western and north-western Himalayas. The medicinal plant is heavily exploited for root and rhizome. Due to its endemic nature and the high rate of exploitation from its natural habitat, this species had become critically endangered. The phytochemical screening of the plant revealed that the plant contains some vital phyto-constituents (iridoids, xanthones, C-glucoxanthone mangiferin, and C-glucoflavones) that have a medicinal value for various acute and chronic diseases. Several researchers have carried out experimental work to validate the folkloric use of the medicinal plant for different ailments like antibacterial, antioxidant, anti-arthritic, anti-inflammatory, analgesic activities and anti-diabetic activity. However, it is yet to be confirmed the antifungal activity of the same plant. Because of endemic nature and high rate of exploitation there is need for alternative method called bio-prospecting of Endophytes from the plant, to carry out the production and characterization of bioactive metabolites for pharmacological uses and can become a conservative tool for the medicinal plant.

1. Introduction

The common name of Gentiana has been derived from “Gentius”, a king of Illyria (Europe), who is believed to have discovered the medicinal value of the Gentian root. In fact, the specific name of G. kurroo Royle (Figure 1) is from the local name for the root of the plant, “Karu” meaning bitter. G. kurroo Royle commonly known as “Indian Gentian” in English or Himalayan Gentian, “Karu” in Hindi, “Traayamaana” in Sanskrit [1,2,3], however in Kashmir Himalaya it is called as “Nilkanth” but Bakarwals (high-altitude goatherds/shepherds) living in the area of Sinthon top (asl-3800 m) and Daksum (asl-2438 m), named it “Tazakhzand” in their local language. G. kurroo Royle is rosette-forming perennial herb and a critically endangered medicinal plant [4].

2. Habitat and Distribution of G. kurroo Royle

G. kurroo Royle belongs to the family Gentianaceae (family of flowering plants). The Gentianaceae family is represented by more than 90 genera and 1650 species; they are annual and perennial herbs or shrubs, native to northern temperate areas of the world. Nearly 360 species of genus Gentiana have been recorded [5,6,7,8], 62 species with 16 genera out of the total number are observed in temperate regions of India [9,10]. The species is distributed in the Himalayan region across India, Pakistan and Nepal [11]. It is endemic to the north-western Himalayas [12] and commonly grows in Kashmir, Himachal Pradesh, and adjoining hills of the north-western Himalayas at an altitude of 1500–3000 m asl [8,10,13,14] In Kashmir, it is usually found on south facing steeper slopes along dry and rocky sloppy grasslands and sparsely shrubby scrubs [15], whereas, in Himachal Pradesh (1700–2000 m), it has become intermittent in subalpine to alpine meadows [10,16]. More than 80% of the population decline of the species has taken place in India in a time period of ten years [17,18]. Therefore, the species is assessed as critically endangered [19]. India has the majority of the geographical range (80%) and therefore, situation in India is considered as the representative of the global population of the species.
The Gentiana family is characterized by six genera and 55 species in the Kashmir Himalaya, an important domain of the Himalaya hotspot [20]. The genus Gentiana has high diversity in this province with 35 species. Out of these species, 31 reach alpine or sub-alpine levels [21]. G. kurroo Royle was described by [22] as a new plant species on the basis of specimens collected from the areas of the north-western Himalayas (Mussooree, Kuerkoolee, Budraj and Shimla). G. kurroo was first reported in the Kashmir Himalaya by [23] at an altitude of 1850–2000 m (a.s.1) from the Pahalgam area, followed by [24] from the localities of Kangan and Wangat. In many floristic works dealing with Kashmir Himalaya, the plant species has been included, not based on the author’s personal collections but by citing the pre-1943 collections ([21,25,26,27]. Due to the large scale exploitation the plant extinct from the Dachigam National Park, however, G. kurroo Royle has been rediscovered in November, 2004, on the floristic expedition to the Dachigam National Park in Kashmir Himalaya after more than sixty years since it was reported earlier [14]. G. kurroo Royle known to be adulterated/substituted with roots of Gentiana tenella, Picrorrhiza kurroa, Gentiana decumbens, Exacum bicolor [28,29,30,31] for its high demand in international market and limited supply from natural systems. However, the purity and authenticity of crude drugs can be performed by macroscopic, microscopic and anatomical observation besides chemical and ash analysis [32,33,34].

3. Life Cycle of G. kurroo Royle

G. kurroo shows propagation through rhizome cuttings, seeds, somatic embryogenesis and micro proliferation of shoot nodal segments. The shoot system of the G. kurroo is represented by flowering branches only with culine leaves. The stem is a modified rhizome whereas the root system consists of the rhizome and adventitious root. Flowering starts from the third week of August to first week of November with the peak from 15 September to 20 October. On an average a plant produces 20 flowers, and the ideal time for seed harvest is the first fortnight of November [10,35].

4. Rationale of the Study

Traditionally, a number of plants and their preparations have been in use for the treatment of different diseases. Awareness of plant-based medications and therapeutics are continuously increasing worldwide, hence the recognition and demand. However, very few of these have been validated scientifically through rigorous in vivo animal studies and clinical trials. Most of the available scientific data confirming the disease curing potential of traditionally used plants but lacks systematic studies on their mode of action, efficacy, stability, toxicity and safety. In-depth scientific validation studies are required to validate the traditional medications as alternative and complementary drugs for the treatment of various diseases.
Although little work has been carried out regarding G. kurroo Royle, maximum efforts have still been put in to compile all the research work in the present comprehensive review. The experimental work carried out by scientists to investigate the promising phytochemicals and to validate the folkloric use of G. kurroo Royle through different activities; for example, antimicrobial, antioxidant, anti-arthritic, anti-inflammatory, analgesic and anti-diabetic activities have been highlighted in this review paper.

5. Phytochemistry

The family Gentianaceae have taxonomically useful types of compounds and pharmacological actions. The various compounds like iridoids, xanthones, C-glucoxanthone mangiferin, and C-glucoflavones have been recorded. The iridoids (mostly secoiridoid glucosides) appear to be present in all species studied [36], whereas 90 different compounds of iridoids have been reported from 127 species in 24 genera. Although Xanthones are not commonly present in Gentianaceae, about 100 different compounds have been reported from 121 species in 21 genera. However, the C-glucoxanthone mangiferin has a more limited distribution than the iridoids and the normal xanthones, although it has been reported from 42 species in seven genera. Similarly, only nine different compounds of C-glucoflavones have been reported so far from a total of 78 species in bube genera and are much less variable than the iridoids and the xanthones [37]. The family contains most bitter compounds; even at a dilution of 1:58,000,000, one tastes bitter, known as Amarogentin (Chirantin) (Figure 2), a glycoside, and is used as a scientific basis for measuring bitterness [38,39,40,41]. Bitter products have been traditional remedies for loss of appetite and fever and are still included in many “tonic” preparations [42,43]. In the present case, it is not possible to document the phytochemistry of all species of the family Gentianaceae; therefore only one species (G. kurroo Royle) of genus Gentiana will be taken into detailed consideration because of its nature as a critically endangered species in the Kashmir Himalayas, as it is mostly extracted for the different ailments of human diseases.
The phytochemical screening of G. kurroo Royle revealed various vital phytoconstituents as depicted in Table 1. The quantitative estimation (%) of chemical constituents and fraction of flavonoids of flower tops of G. kurroo Royle has been depicted in Table 2, whereas the total flavonoid and phenolic content of the leaf and root extract are given in Table 3. However, besides flavonoid and phenolic content, there are other constituents present in the root extract, as depicted in Table 4. The critically endangered drug herb is mostly extracted from its natural habitat for root and rhizome. The roots and rhizomes of G. kurroo Royle have been recorded in the Indian pharmaceutical codex [8]. The root and rhizome are source of Iridoid glycosides-gentiopicrine, gentiamarin, amaroswerin, and the alkaloid gentianine [46,47,48]. The dried roots contain 20% of a yellow, transparent, and brittle resin [23,29,48], aucubin, catalpol, 6-O-vanilloyl catalpol, 6-O-cinnamoyl catalpol, [49,50]. However, the leaves also contain some of the important bitter compounds; noticeably moreso than the roots [51]. Leaves contain iridoid glycoside 2′-(2,3-dihydroxybezoyloxy)-7-ketologanin [52] and about 16 volatile aroma compounds [53]. Some of the principal components in the leaf extracts of G. kurroo Royle are dimethyl sulphide (14.7%), 2-ethylfuran (17.5%), 1,8-cincole (7.8%), a-terpinyl acetate (23.5%) and methandriol (12.6%). The other chemical components with lesser percentage are 1,3-propanediol (2.1%), 2-methyl sulphide (2.1%), 3-methyl butanol (4.4%), pentanal (3.2%), hexanal (2.7%) and 7-oxabicyclo (4,1,0)-heptane (2.0%) ([53]). Some other components isolated are morroniside and gentiopicroside [54].

6. Ethno-Pharmacology

G. kurroo Royle has been found to have enormous medicinal properties reported by several researchers. The medicinal values date back to when human beings first got to know natural cures for different diseases from natural products. In folkloric treatment, leaf powder of G. kurroo (Neilkanth) is mixed with oil and is applied on ulcer and fungal infection [66]. However, the root of G. kurroo is used in stomach-ache and in urinary infections [67]; the root with ginger root powder is also used for curing high fevers [68]. The roots were also used as bitter tonic, and as an antiperiodic, expectorant, astringent, stomachic, anti-inflammatory, antipsychotic, sedative, anthelmintic and antibacterial [69]. Gentianine (alkaloid) in G. kurroo possesses anti-infammatory, analgesic, anticonvulsant, hypotensive, antipsychotic, sedative, diuretic, antimalarial, anti-amoebic and antibacterial properties and Amaroswerin acts as gastro-protective [48], whereas some traditional doctors use the whole plant against cough, fever, headache, liver ailments and as a blood purifier [70]. The drug obtained from G. kurroo is very helpful in removing all kinds of weakness and overtiredness of body from prolonged illness, recovers digestive system and lack of appetite [71]. In the Ayurvedic (Unani) system of medicine, the flower tops (Gule-Ghafis) are used for treatment of inflammation, pain, antipyretic and hepatitis [61,62] and in the preparation of tonics for stomachic [72]. It is also curative for the skin disease leucoderma, leprosy, dyspepsia, colic, anorexia, flatulence, helminthiosis, anti-inflammatory, amenorrhea, dysmenorrhoeal, haemorrhoids, strangury, constipation, urinary infections as an antiseptic, bitter tonic, cholagogue and bronchial asthma [46,73,74]. However, there are some scientific validations of the folkloric uses of the critically endangered medicinal plant G. kurroo Royle.

7. Antibacterial Activity

The recent study has revealed the antibacterial and antioxidant activity of the extracts of Gentiana kurroo, as the extracts prevented the growth of both Gram positive and Gram negative bacteria. The extracts of roots and leaves of G. kurroo possessed relatively higher antibacterial activity against Gram positive bacteria than the Gram negative. The possible reason for antibacterial activity is due to high content of flavonoids, involved in the inhibition of nucleic acid biosynthesis and metabolic processes [75,76,77]. The antibacterial activity of root extract was found to be comparatively higher than that of leaf extract and it was highest against Micrococcus luteus (0.15 mg/mL) and lowest activity against Salmonella enteritidis (0.75 ± 0.05). Leaf extract also exhibited a similar trend as shown in Table 5, whereas the minimal inhibitory concentration (MIC) values were higher than those of the root extract [59]. However, the study does not find out the peculiar bioactive molecule that specifically regulates the growth of bacteria, but has successfully proved that G. kurroo could be a potential source of broad spectrum antibacterial agents and can be used as preservatives in food and non-food systems; thus, further phytochemical analysis is required for the isolation of bioactive molecules from the plant that may show a broad spectrum of pharmacological activities.

8. Antioxidant Activity

The methanolic extracts of leaves and roots of G. kurroo showed high phenolic and flavonoid content. Phenolic compounds are important plant constituents for their free radical scavenging ability, enabled by their hydroxyl groups, and the total phenolic concentration might be used as a source for rapid screening of antioxidant activity [78] and are also involved in the oxidative stress tolerance of plants. Flavonoids are highly effective scavengers of most oxidizing molecules concerned with several diseases [79,80]. On the other hand, flavonoids suppress reactive oxygen formation, chelate trace elements involved in free-radical production, scavenge reactive species, up-regulate and protect antioxidant defences [81]. The methanolic extracts of root as compared to the methanolic extract of leaves showed comparatively high antioxidant activity, which could be related to the total flavonoid and phenolic content of the two extracts [59,80] (Table 6) (Figure 3 and Figure 4).

9. Anti-Arthritic and Anti-Inflammatory Activity

The recent study [84] and [60] has shown positive results from the extracts of G. kurroo regarding acute and chronic anti-Inflammatory test. To determine the acute inflammatory effect, rat carrageenin-induced paw edema model was used. Different plant extracts were screened for anti-inflammatory activity at a dose of 250 mg/kg body weight. The maximum potential for suppressing the inflammatory response was shown by methanolic extract of G. kurroo. The observed inhibitory effect in the paw edema of Wistar rats was 47.62% and it was found to be significant (p < 0.05) as compared to control group (55.24%). However, a dose of 750 mg/kg body weight has shown maximum activity (67.27%) which was even found to be higher than that of the standard drug (56.36%). The results were found to be statistically significant compared to control group but non-significant with standard group at p < 0.05.
Chronic Anti-Inflammatory Test: For this study, mycobacterium-induced adjuvant arthritis as a model of chronic inflammation was used. Male Wistar rats were taken in seven groups, with each group having the same number of animals (n = 5). The results revealed that the methanolic extract has a dose as well as time-dependent inhibitory effect on the edema formation (Figure 5). The increased activity with increased doses may be due to high concentration of bioactive agent/s in the extract. Methanolic extract of G. kurroo has more pronounced effect as compared to other extracts and consequently indicates the inhibition of chemical mediators of inflammation. The results were found to be very significant as related to arthritic control at p < 0.05. It may be due to the incidence of more bioactive agent(s) in the extract [60,85]. Anti-inflammatory property of G. kurroo could be related to secondary metabolites such as terpenoids or flavonoids; monoterpenoids such as camphene, borneol, and β-pinene have similar properties [55,56], and flavonoids such as 6-methoxytricin show anti-inflammatory and analgesic activities [57]. This could also be because of the inhibition of proinflammatory cells [60,85]. Although the study related to the anti-inflammatory drug obtained from a methanolic extract of G. kurroo against rheumatoid arthritis is prolific, it has the limitation of the possible mechanism and the identification of the bioactive compound from the extract of Gentiana kurroo; however, it is confirmed that the G. kurroo serves as a drug source against inflammation and rheumatoid arthritis.

10. Analgesic Activity

The study being carried out by [58] on the analgesic activity of G. kurroo was based on two tests: an acetic acid-induced writhing test was used for detecting both central and peripheral analgesia, whereas the hot plate test is most sensitive to centrally-acting analgesics. In the acetic acid-induced writhing test, the methanolic extract of G. kurroo root at a dose of 250 and 500 mg/kg body weight revealed a significant (p < 0.05) decrease in number of writhings (63.38% and 73.70% inhibition) provoked by acetic acid in a dose-dependent manner, and the results were comparable with the standard drug diclofenac sodium (71.61% inhibition). It could be possible that extracts produced analgesic effect due to the inhibition of synthesis or action of prostaglandin [86]. However, in the case of Eddy’s hot plate test, the extract showed a significant (p < 0.05) rise in reaction time (increase threshold potential of pain) in a dose-dependent manner to the thermal stimulus at different time of observation (0–120 min) in comparison with control. Thus, results revealed that G. kurroo Royle possesses potent analgesic effect against different stimuli. The possible mechanism was found to be due to an inhibition of both peripherally and centrally-mediated nociceptive.

11. Anti-Diabetic Activity

The plant is also used against diabetes [87]. There is no literature available in support of the scientific validation of anti-diabetic activity of G. kurroo Royle; however, the recent study held in 2017 confirmed the counter-diabetic capability of G. kuroo Royle. The experiments carried out on rats, shown the extracts of G. kurroo Royle were found to improve the glycaemic control in oral glucose tolerance tests as it was observed even in normal rats; the glucose load is quickly cleared by the plant extracts. The methanolic and hydroethanolic extracts (each at the dose level of 500 mg/kg of body weight) were found to overcome the main symptoms of the diabetes, i.e., polyphagia, polydipsia and polyuria. It was also observed the weight loss to lessen in diabetic rats. It has a controlling power in hyperglycaemia and can viably work against other metabolic deviations created by diabetes in rats. The possible reason for the antidiabetic activity of G. kurroo Royle are due to bioactive principles like Swertiamarin, swertisin and lupeol [88]. The systematic study is required for the understanding of suitable mechanism of hypoglycaemic potential of the plant extracts of G. kurroo Royle.

12. Conservation Strategy

Traditional extraction of medicinal plants on a large scale could be minimized so as to save these from becoming critically endangered. This could be achieved through the exploration of new ecological niches having prospective sources of natural bioactive agents for diverse pharmaceutical, agriculture and industrial applications and should be renewable, eco-friendly and easily obtainable [89]. The discovery of novel bioactive molecules played major role in the search for new drugs and are the most potent sources for the innovation of novel bioactive molecules. The most prominent producers of natural products (compounds derived from living organisms) can originate within different groups of organisms including plants and microorganisms (fungi, bacteria, and actinomycetes) [90]. The techniques involved in the discovery of natural products are isolation, structural elucidation and establishing the bio-synthetic pathway of the secondary metabolites. The area is of substantial interest to scientists due to the structural diversity, complexity and various bioactivities of isolated compounds [91] such as, bio-prospecting of endophytes from medicinal plants is one of the techniques to obtain the bioactive potential metabolites for the preparation of new medicines. Bio-prospecting of endophytes from medicinal plants will be the innovative method for drug discovery which has least environmental consequences and can play significant role in conservation of critically endangered medicinal plants.

13. Conclusions

The review highlights the important vital phytochemicals of the medicinal plant G. kurroo Royle, and various experiments have shown scientifically the potential of antibacterial, antioxidant, anti-arthritic, anti-inflammatory, analgesic activities and anti-diabetic activity. The outcome of the study validates the folkloric use of the medicinal plant; however, the antifungal activity of the same plant is yet to be confirmed. The traditional extraction of medicinal plants on a large scale could be minimized by adopting modern techniques, called the bio-prospecting of endophytes, from the medicinal plant for the production and characterization of bioactive metabolites for pharmacological uses that may show a broad spectrum of pharmacological activities and can become a conservative measure for the critically endangered medicinal plant.

Acknowledgments

We are very thankful to all the authors whose work has been cited in this paper.

Author Contributions

B.M.S. searched out different research papers through different databases online and framed the whole manuscript. B.A.G. contributed his own work in the paper and checked the whole manuscript. A.H.W. cross check the manuscript and made some necessary corrections. All the authors read and approved the final manuscript.

Conflicts of Interest

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

References

  1. Jain, S.K. Indian Gentians. In Medicinal Plants; National Book Trust of India: New Delhi, India, 1968; pp. 73–74. [Google Scholar]
  2. Satyavati, G.V.; Raina, M.K.; Sharma, M. Medicinal Plants of India; ICMR: New Delhi, India, 1976; Volume 1, 429p. [Google Scholar]
  3. Khare, C.P. Indian Medicinal Plants: An Illustrated Dictionary; Springer: Berlin/Heidelberg, Germany; New York, NY, USA, 2007; pp. 283–284. [Google Scholar]
  4. Tandon, V. Status of Collection, Conservation, Trade and Potential for Growth in Sustainable Use of Major Medicinal Plant Species Found in the Great Himalayan National Park and Its Environs in Kullu District of Himachal Pradesh; Wildlife Institute of India: Dehradun, India, 1997. [Google Scholar]
  5. Judd, W.S.; Campbell, C.S.; Kellogg, E.A.; Stevens, P.E. Plant Systematics: A Phylogenetic Approach; Sinauer Associates, Inc.: Sunderland, MT, USA, 1999. [Google Scholar]
  6. Struwe, L.; Albert, A. Gentianaceae Systematics and Natural History; Cambridge University Press: Cambridge, UK, 2002. [Google Scholar]
  7. Daniel, M.; Sabnis, S.D. Chemical systematics of family Gentianaceae. Curr. Sci. 2002, 47, 109–111. [Google Scholar]
  8. Behera, M.C.; Raina, R. G. kurroo Royle-A critically endangered bitter herb. Int. J. Med. Arom. Plants 2012, 2, 22–29. [Google Scholar]
  9. Sunita, A.; Bhattacharyya, U.C. Some nomencultural notes on family Gentianaceae. Bull. Bot. Surv. India 1982, 22, 184–185. [Google Scholar]
  10. Raina, R.; Behera, M.C.; Chand, R.; Sharma, Y. Reproductive biology of Gentiana kurroo Royle. Curr. Sci. 2003, 85, 667–670. [Google Scholar]
  11. Polunin, O.; Stainton, A. Flowers of Himalaya; Oxford University Press: New Delhi, India, 1984. [Google Scholar]
  12. Hooker, J. D. The Flora of British India (Vol. IV); L. Reeve and Co., Ltd.: London, UK, 1885. [Google Scholar]
  13. Chaudhary, H.J.; Wadhwa, B.M. Flora of Himachal Pradesh (Flora of India Series 2); Botanical Survey of India: New Delhi, India, 1984. [Google Scholar]
  14. The Wealth of India. A Dictionary of Indian Raw Material and Industrial Products; CSIR: New Delhi, India, 2000. [Google Scholar]
  15. Khuroo, A.A.; Dar, G.H.; Khan, Z.S.; Reshi, Z.A. Observations on Gentiana kurroo Royle, a critically endangered medicinal plant from Kashmir Himalaya, India. Endanger. Species Update 2005, 22, 139–143. [Google Scholar]
  16. Chauhan, N.S. Medicinal and Aromatic Plants of Himachal Pradesh; Indus Publishing Company: New Delhi, India, 1999; ISBN 81-7387-098-5. [Google Scholar]
  17. Goraya, G.S.; Jishtu, V.; Rawat, G.S.; Ved, D.K. Wild Medicinal Plants of Himachal Pradesh: An Assessment of Their Conservation Status and Management Prioritisation; Himachal Pradesh Forest Department: Shimla, India, 2013. [Google Scholar]
  18. Singh, S.K. Flora of Great Himalayan National Park, Himachal Pradesh; Bishen Singh Mahendra Pal Singh: Dehradun, India, 2000; 304p. [Google Scholar]
  19. IUCN. The IUCN Red List of Threatened Species. Version 2015.2. Available online: www.iucnredlist.org (accessed on 23 June 2015).
  20. Mittermeier, R.A.; Robles-Gil, P.; Mittermeier, R.A.; Hoffmann, M.; Pilgrim, J.; Brooks, T.; Mittermeier, C.G.; Lamoreux, J.; Da Fonseca, G.A.B. Hotspots Revisited: Earth’s Biologically Richest and Most Threatened Terrestrial Eco-Regions; Conservation International Arlington: Arlington, VA, USA, 2005. [Google Scholar]
  21. Dhar, U.; Kachroo, P. Alpine Flora of Kashmir Himalaya; Scientific Publishers: Jodhpur, India, 1983. [Google Scholar]
  22. Royle, J.F. Illustrations of the Botany and other Branches of the Natural History of the Himalayan Mountains, and of the Flora of Cashmere; Volume Plates. Reprint 1970; Today & Tomorrow’s Printers & Publishers: New Delhi, India, 1970; 71p. [Google Scholar]
  23. Coventry, B.O. Wild Flowers of Kashmir (Series-III); Raithby, Lawerence and Co., Ltd.: London, UK, 1927. [Google Scholar]
  24. Blatter, E. Beautiful Flowers of Kashmir (Vol. II); John Balc, Danielsson: London, UK, 1929. [Google Scholar]
  25. Javeid, G.N. Flora of Srinagar. Ph.D. Thesis, University of Kashmir, Srinagar, J&K, India, 1970, unpublished. [Google Scholar]
  26. Sharma, B.M.; Jamwal, P.S. Flora of Upper Lidder Valleys of Kashmir Himalaya (Vol-II); Scientific Publishers: Jodhpur, India, 1998. [Google Scholar]
  27. Dar, G.H.; Bhagat, R.C.; Khan, M.A. Biodiversity of Kashmir Himalaya; Valley Book House: Srinagar, J&K, India, 2001. [Google Scholar]
  28. Datta, S.C.; Mukerji, B. Pharmacognosy of Indian Root and Rhizome Drugs; Pharmacognosy Laboratory Bulletin No. 1; Ministry of Health, Government of India Press: New Delhi, India, 1949; pp. 95–97.
  29. Anonymous. The Wealth of India: A Dictionary of Indian Raw Material and Industrial Products; Publication and Information Directorate CSIR: New Delhi, India, 1956; Volume 4, pp. 123–125. [Google Scholar]
  30. Nadkarni, K.M. Gentiana kurroo Royle. In Indian Materia Medica; Popular Prakashan: Bombay, India, 1976; pp. 573–576. [Google Scholar]
  31. Sreelatha, U.; Baburaj, T.S.; Kutty, N.C.; Nazeem, P.; Bhaskar, J. Cultivation prospects of Exacum bicolor Royle: An endangered, ornamental and anti-diabetic herb. Nat. Prod. Radiance 2007, 6, 402–404. [Google Scholar]
  32. Trease, G.E. A Text Book of Pharmacognosy; Tindall and Cox: London, UK, 1949; 640p. [Google Scholar]
  33. Behera, M.C.; Raina, R. Histology and ash analysis of G. kurroo Royle: An endangered medicinal plant. Int. J. Farm Sci. 2011, 1, 75–82. [Google Scholar]
  34. Mangal, A.K.; Rath, C.; Tewari, D.; Dutta, S.; Srikanth, N.; Dhiman, K.S. Microscopical and preliminary physicochemical studies of two important endangered Ayurvedic medicinal plants Kutki and Trayamana to establish their identity. J. Drug Res. Ayurvedic Sci. 2017, 2, 18–22. [Google Scholar] [CrossRef]
  35. Behera, M.C.; Raina, R. Cytomorphology of Gentiana kurroo: An important bitter plant of temperate Himalaya. J. For. Res. 2011, 22, 621–626. [Google Scholar] [CrossRef]
  36. Rodriguez, S.; Marston, A.; Wolfender, J.L.; Hostettmann, K. Iridoids and secoiridoids in the Gentainaceae. Curr. Org. Chem. 1998, 2, 627–648. [Google Scholar]
  37. Jensen, S.R.; Schripsema, J. Chemotaxonomy and Pharmacology of Gentianaceae. In Gentianaceae—Systematics and Natural History; Struwe, L., Albert, V., Eds.; Cambridge University Press: Cambridge, UK, 2002; pp. 573–631. [Google Scholar]
  38. Vanhaelen, M.; Vanhaelen, F.R. Quantitative determination of biologically active constituents in medicinal plant crude extracts by thin layer chromatography densitometry. J. Chromatogr. 1983, 281, 263–271. [Google Scholar] [CrossRef]
  39. Ishimaru, K.; Sudo, H.; Satake, M.; Matsunaga, Y.; Hasegawa, Y.; Takemoto, S.; Shimomura, K. Amarogentin, amaroswerin and four xanthones from hairy root cultures of Swertia japonica. Phytochemistry 1990, 29, 1563–1565. [Google Scholar] [CrossRef]
  40. Arino, A.; Arberas, I.; Leiton, M.J.; de Renobales, M.; Dominguez, J.B. The extraction of yellow gentian root (Gentiana lutea L.). Z. Lebensmittelunters. Forsch. A 1997, 205, 295–299. [Google Scholar]
  41. Jiang, R.W.; Wong, K.L.; Chan, Y.M.; Xu, H.X.; But, P.P.H.; Shaw, P.C. Isolation of iridoid and secoiridoid glycosides and comparative study on Radix gentianae and related adulterants by HPLC analysis. Phytochemistry 2005, 66, 2674–2680. [Google Scholar] [CrossRef] [PubMed]
  42. Hostettmann-Kaldas, M.; Hostettmann, K.; Sticher, O. Xanthones, flavones, and secoiridoids of American Gentiana species. Phytochemistry 1981, 20, 443–446. [Google Scholar] [CrossRef]
  43. Inouye, H.; Nakamura, Y. Über die Monoterpenglucoside und Verwandte Naturstoffe—XIV. Die Struktur der beiden stark bitter schmeckenden Glucoside Amarogentin und Amaroswerin aus Swertia japonica. Tetrahedron 1971, 27, 1951–1966. [Google Scholar] [CrossRef]
  44. Keil, M.; Hartle, B.; Guillaume, A.; Psiorz, M. Production of Amarogentin in Root Cultures of Swertia chirata. Planta Med. 2000, 66, 452–457. [Google Scholar] [CrossRef] [PubMed]
  45. Sharma, N.; Chandel, K.P.S.; Paul, A. In vitro propagation of Gentiana kurroo—An indigenous threatened plant of medicinal importance. Plant Cell Tissue Organ Cult. 1993, 34, 307–309. [Google Scholar] [CrossRef]
  46. Niiho, Y.; Yamazaki, T.; Nakajima, Y.; Yamamoto, T.; Ando, H.; Hirai, Y.; Toriizuka, K.; Ida, Y. Gastro protective effects of bitter principles isolated from Gentian root and Swertia herb on experimentally induced gastric lesions in rats. J. Nat. Med. 2006, 60, 82–88. [Google Scholar] [CrossRef]
  47. Singh, A. Phytochemicals of Gentianaceae: A review of pharmacological properties. Int. J. Pharm. Sci. Nanotechnol. 2008, 1, 33–36. [Google Scholar]
  48. Sarg, M.; El-Domiaty, M.; Salama, O.M.; Bishr, M.M.; El-Gindy, A.R. Pharmacognostical study of the rhizomes and roots of Gentiana kurroo Royle. Mansoura J. Pharm. Sci. 1990, 6, 49–72. [Google Scholar]
  49. Sarg, T.; Salama, O.; Domiaty, M.E.; Bisher, M.; Mansour, E.S.; Weight, E. Iridoid Glucosides from Gentiana kurroo Royle. Alex. J. Pharm. Sci. 1991, 5, 84–86. [Google Scholar]
  50. Raina, R.; Chand, R.; Sharma, Y. Conservations strategies of some important medicinal plants. Int. J. Med. Aromat. Plants 2011, 1, 342–347. [Google Scholar]
  51. Wani, B.; Ramamoorthy, D.; Rather, M.A.; Ganai, B.A.; Masood, A.; Zargar, M.A.; Wani, I.H. Headspace solid-phase microextraction (HS-SPME) Gas Chromatography Mass Spectrometric (GC-MS) analysis of the volatile aroma components of Gentiana kurroo Royle. J. Pharm. Res. 2011, 4, 2943–2945. [Google Scholar]
  52. Inouye, H.; Nakamura, Y. Monoterpene glucosides and related natural products. XVI. Occurrence of secoiridoid glucosides in gentianaceous plants especially in the genera Gentiana and Swertia. Yakugaku Zasshi 1971, 91, 755–759. [Google Scholar] [CrossRef] [PubMed]
  53. Kumar, V.; Chand, R.; Auzi, A.; Ikeshiro, Y.; Sarkar, S.D. 2′-(2,3-dihydroxybezoyloxy)-7-ketologanin: Novel Iridoid glycoside from the leaves of Gentiana kurroo. Die Pharm. 2003, 58, 668–670. [Google Scholar]
  54. Lin, C.T.; Chen, C.J.; Lin, T.Y.; Tung, J.C.; Wang, S.Y. Anti-inflammation activity of fruit essential oil from Cinnamomum insularimontanum Hayata. Bioresour. Technol. 2008, 99, 8783–8787. [Google Scholar] [CrossRef] [PubMed]
  55. Tung, Y.T.; Chua, M.T.; Wang, S.Y.; Chang, S.T. Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs. Bioresour. Technol. 2008, 99, 3908–3913. [Google Scholar] [CrossRef] [PubMed]
  56. Yin, Y.; Gong, F.Y.; Wu, X.X.; Sun, Y.; Li, Y.H.; Chen, T.; Xu, C.Q. Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J. Ethnopharmacol. 2008, 120, 1–6. [Google Scholar] [CrossRef] [PubMed]
  57. Wani, B.; Ramamoorthy, D.; Ganai, B. Preliminary phytochemical screening and evaluation of analgesic activity of methanolic extract of roots of Gentiana kurroo Royle in experimental animal models. Int. J. Pharm. Pharm. Sci. 2011, 3, 164–166. [Google Scholar]
  58. Baba, S.A.; Malik, S.A. Evaluation of antioxidant and antibacterial activity of methanolic extracts of G. kurroo Royle. Saudi J. Biol. Sci. 2014, 21, 493–498. [Google Scholar] [CrossRef] [PubMed]
  59. Mubashir, K.; Ganai, B.A.; Ghazanfar, K.; Akbar, S.; Rah, B.; Tantry, M.; Masood, A. Anti-inflammatory and immune modulatory studies on LC-MS characterised methanol extract of Gentiana kurroo Royle. BMC Complement. Altern. Med. 2017, 17, 78. [Google Scholar] [CrossRef] [PubMed]
  60. Dymock, W.; Warden, C.J.H.; Hooper, D. Pharmacographica Indica; Trubner and Co., Ltd.: London, UK, 1890; Volume I. [Google Scholar]
  61. Ibn-e-Sina. Kitab al-Qanoon Fi’l Tibb; Mataba Nami: Lucknow, India, 1906; Volume 2, pp. 78–79. [Google Scholar]
  62. Latif, A.; Khan, T.F.; Afaq, S.H. Anti-inflammatory activity of flower tops of Gentiana kurroo Royle extract. Pharmacologyonloine 2006, 3, 575–580. [Google Scholar]
  63. Chang, C.; Yang, M.; Wen, H.; Chern, J. Estimation of Total Flavonoid Content in Propolis by Two Complementary Colorimetric Methods. J. Food Drug Anal. 2002, 10, 178–182. [Google Scholar]
  64. Singleton, V.L.; Orthofer, R.; Lamuela-Raventós, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods Enzymol. 1999, 299, 152–178. [Google Scholar]
  65. Unial, B.; Shiva, V. Traditional knowledge on medicinal plants among rural women of Garhwal Himalayas, Uttaranchal. Indian J. Tradit. Knowl. 2005, 4, 259–266. [Google Scholar]
  66. Gilani, S.A.; Qureshi, R.A.; Gilani, S.J. Indegenious uses of some important ethnomedicinal herbs of Ayubia national park, Abbottabad, Pakistan. Ethnobot. Leafl. 2006, 10, 385–393. [Google Scholar]
  67. Sharma, G.K. Medicinal plants folklore and Ayurvedic system of medicine in the Indo-Tibetan outer Himalayas. J. Tenn. Acad. Sci. 2000, 75, 38–41. [Google Scholar]
  68. Kirtikar, K.R.; Basu, B.D. Indian Medicinal Plants; Bishen Singh Mahendra Pal Sigh: Dehradun, India, 1935; Volume 3, pp. 1661–1662. [Google Scholar]
  69. Sharma, P.K.; Sethi, G.S.; Sharma, S.K.; Sharma, T.K. Ethnomedicinal observations among the inhabitants of cold desert area of Himachal Pradesh. Indian J. Tradit. Knowl. 2006, 5, 358–361. [Google Scholar]
  70. Martindale, W. The Extra Pharmacopoeia, 28th ed.; Reynolds, J.E.F., Ed.; The Pharmaceutical Press: London, UK, 1982. [Google Scholar]
  71. Qureshi, R.A.; Ghufran, M.A.; Gilani, S.A.; Sultan, K.; Ashraf, M. Ethnobotanical studies of selected medicinal plants of Sudhan Gali and Ganga chotti hills, district bagh Azad Kashmir. Pak. J. Bot. 2007, 39, 2275–2283. [Google Scholar]
  72. Pullaiah, T. Medicinal Plants in India; Regency Publication: New Delhi, India, 2002; Volume 1, 267p. [Google Scholar]
  73. Chopra, R.N.; Nayar, S.L.; Chopra, I.C. Glossary of Indian Medicinal Plants; CSIR: New Delhi, India, 1956. [Google Scholar]
  74. Warrier, P.K.; Nambier, V.P.K.; Ramakutty, C. Indian Medicinal Plants: A Compendium of 500 Species; Orientlongman Pvt Ltd.: Madras, India, 1995; Volume 3, pp. 72–75. [Google Scholar]
  75. Cushnie, T.P.T.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343–356. [Google Scholar] [CrossRef] [PubMed]
  76. Siler, B.; Misic, D.; Nestorovic, J.; Banjanac, T.; Glamoclija, J.; Sokovic, M.; Ciric, A. Antibacterial and antifungal screening of Centaurium pulchellum crude extracts and main secoiridoid compounds. Nat. Prod. Commun. 2010, 10, 1525–1530. [Google Scholar]
  77. Orak, H.H.; Yagar, H.; Isbilir, S.S.; Demirci, A.S.; Gumus, T.; Ekinci, N. Evaluation of antioxidant and antimicrobial potential of strawberry tree (Arbutus unedo L.) leaf. Food Sci. Biotechnol. 2011, 20, 1249–1256. [Google Scholar] [CrossRef]
  78. Yi, O.; Jovel, E.M.; Towers, N.G.H.; Wahbe, T.R.; Cho, D. Antioxidant and antimicrobial activities of native Rosa sp. from British Columbia, Canada. Int. J. Food Sci. Nutr. 2007, 58, 178–189. [Google Scholar] [CrossRef] [PubMed]
  79. Bravo, L. Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev. 1998, 56, 317–333. [Google Scholar] [CrossRef] [PubMed]
  80. Wani, B.A.; Ramamoorthy, D.; Rather, M.A.; Arumugam, N.; Qazi, A.K.; Majeed, R.; Hamid, A.; Ganie, S.A.; Ganai, B.A.; Anand, R.; et al. Induction of apoptosis in human pancreatic MiaPaCa-2 cells through the loss of mitochondrial membrane potential by Gentiana kurroo root extract and LC-ESI-MS analysis of its principal constituents. Phytomedicine 2013, 20, 723–733. [Google Scholar] [CrossRef] [PubMed]
  81. Agati, G.; Azzarello, E.; Pollastri, S.; Tattini, M. Flavonoids as antioxidants in plants: Location and functional significance. Plant Sci. 2012, 196, 67–76. [Google Scholar] [CrossRef] [PubMed]
  82. Villano, D.; Fernandez-Pachon, M.S.; Moya, M.L.; Troncoso, A.M.; Garcıa-Parrilla, M.C. Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta 2007, 71, 230–235. [Google Scholar] [CrossRef] [PubMed]
  83. Vyas, D.; Kumar, S. Purification and partial characterization ofa low temperature responsive Mn-SOD from tea (Camellia sinensis (L.) O. Kuntze.). Biochem. Biophys. Res. Commun. 2005, 329, 831–838. [Google Scholar] [CrossRef] [PubMed]
  84. Mubashir, K.; Ganai, B.A.; Ghazanfar, K.; Akbar, S. Evaluation of Antiarthritic Potential of Methanolic Extract of Gentiana kurroo Royle. Arthritis 2014, 2014, 810615. [Google Scholar] [CrossRef] [PubMed]
  85. Mubashir, K.; Ghazanfar, K.; Ganai, B.A.; Akbar, S. Scientific Validation of Gentiana kurroo Royle for anti-inflammatory and immunomodulatory potential. ISRN Inflamm. 2014, 2014, 701765. [Google Scholar] [CrossRef] [PubMed]
  86. Deraedt, R.; Jougney, S.; Benzoni, J.; Peterfalvi, M. Release of prostaglandins E and F in algogenic reaction and its inhibition. Eur. J. Pharmacol. 1980, 61, 16–24. [Google Scholar] [CrossRef]
  87. Selvam, A.B.D. Gentianaceae. Pharmacognosy of Negative Listed Plants; Botanical Survey of India: Kolkata, 2012; pp. 96–105. [Google Scholar]
  88. Ghazanfar, K.; Mubashir, K.; Dar, S.A.; Nazir, T.; Hameed, I.; Ganai, B.A.; Akbar, S.; Masood, A. Gentiana kurroo Royle attenuates the metabolic aberrations in diabetic rats; Swertiamarin, swertisin and lupeol being the possible bioactive principles. J. Complement. Integr. Med. 2017, 14. [Google Scholar] [CrossRef] [PubMed]
  89. Liu, C.H.; Zou, X.W.; Lu, H.; Tan, R.X. Antifungal activity of Artemisia annua endophyte cultures against phytopathogenic fungi. J. Biotechnol. 2001, 88, 277–282. [Google Scholar] [CrossRef]
  90. Selim, K.A.; El-Beih, A.A.; Abdel-Rahman, T.M.; El-Diwany, A.I. Biology of Endophytic Fungi. Curr. Res. Environ. Appl. Mycol. 2012, 2, 31–82. [Google Scholar]
  91. Suryanarayanan, T.S.; Thirunavukkarasu, N.; Govindarajulu, M.B.; Sasse, F.; Jansen, R.; Murali, T.S. Fungal endophytes and bioprospecting. Fungal Biol. Rev. 2009, 23, 9–19. [Google Scholar] [CrossRef]
Figure 1. G. kurroo Royle collected from the Khrew village in the district of Pulwama, J&K.
Figure 1. G. kurroo Royle collected from the Khrew village in the district of Pulwama, J&K.
Medicines 04 00074 g001
Figure 2. Structure of Amarogentin—a secoiridoid glycoside. Amarogentin consists of three essential subgroups, the iridoid group, the glucose moiety and the biphenyl-triol rings (Source [44,45]).
Figure 2. Structure of Amarogentin—a secoiridoid glycoside. Amarogentin consists of three essential subgroups, the iridoid group, the glucose moiety and the biphenyl-triol rings (Source [44,45]).
Medicines 04 00074 g002
Figure 3. Free radical scavenging activity of methanolic extracts of leaves and roots of G. kurroo Royle (Source: [59]).
Figure 3. Free radical scavenging activity of methanolic extracts of leaves and roots of G. kurroo Royle (Source: [59]).
Medicines 04 00074 g003
Figure 4. Superoxide scavenging activity of methnolic extracts of leaves and roots of G. kurroo Royle (Source: [59]).
Figure 4. Superoxide scavenging activity of methnolic extracts of leaves and roots of G. kurroo Royle (Source: [59]).
Medicines 04 00074 g004
Figure 5. Inhibition of paw edema in adjuvant arthritis with different concentrations of methanolic extract of G. kurroo Royle (Dose and time dependent) (Source: [85]).
Figure 5. Inhibition of paw edema in adjuvant arthritis with different concentrations of methanolic extract of G. kurroo Royle (Dose and time dependent) (Source: [85]).
Medicines 04 00074 g005
Table 1. Phytoconstituents of G. kurroo Royle.
Table 1. Phytoconstituents of G. kurroo Royle.
Root and RhizomeReferences
Tannins
Alkaloids
Saponins
Glycosides (Gentiopicrine, Gentianine)
Terpenes
Flavonoids
Phenolics
Carbohydrates
Genianic Acid
Pectin
[29]
[50]
[46]
[36]
[47]
[55]
[48]
[56]
[57]
[58]
[59]
[60]
Flower Tops
Alkaloids[61]
[62]
[63]
Flavonoids ( Robinetin-0, Luteolin, Apigenin, Kaempferol, Kaempferid)
Glycosides
Free Phenols
Terpense/Sterols
Leaves
Iridoid Glycoside[53]
[51]
[52]
2′-(2,3-Dihydroxybezoyloxy)-7-Ketologanin
Volatile Aroma Compounds
Dimethyl Sulphide
2-Ethylfuran
1,8-Cincole
Α-Terpinyl Acetate
Methandriol
1,3-Propanediol
2-Methyl Sulphide
3-Methyl Butanol
Pentanol
Hexanal
7-Oxabicylo(4,1,0)-Heptanes
Table 2. Quantitative estimation (%) of chemical components and name of fraction of Flavonoids of flower tops of G. kurroo Royle.
Table 2. Quantitative estimation (%) of chemical components and name of fraction of Flavonoids of flower tops of G. kurroo Royle.
Flower Tops%Name of FlavonoidReference
Phenols2.91 ± 0.07Robinetin-0[63]
Alkaloids0.33 ± 0.02Luteolin
Sterols/Terpenes1.35 ± 0.01Apigenin
Flavonoids0.31 ± 0.01Kaempferol & Kaempferid
Table 3. Total flavonoid (aluminium chloride colorimetric method by [64] and phenolic content (Folin–Ciocalteu reagent method by [65] of root and leaf extracts of G. kurroo Royle.
Table 3. Total flavonoid (aluminium chloride colorimetric method by [64] and phenolic content (Folin–Ciocalteu reagent method by [65] of root and leaf extracts of G. kurroo Royle.
ExtractsTotal Flavonoid Content bTotal Phenolic Content aReference
Leaf extract20 ± 1.534 ± 1.8[59]
Root extract41 ± 2.268 ± 2.4
Each value is a mean of three biological replicas. a mg gallic acid equivalent (GAE)/g DW; b mg rutin equivalent/g DW.
Table 4. Phytochemical screening of methanolic extract of G. kurroo Royle root.
Table 4. Phytochemical screening of methanolic extract of G. kurroo Royle root.
PhytoconstituentsTestReference
Flavonoids++[58]
Tannins++
Phenolics++
Alkaloids+
Saponins+
Cardiac glycosides++
Terpenes++
Carbohydrates+
++: strong presence; +: moderate presence.
Table 5. Antimicrobial activity of G. kurroo extracts (minimal inhibitory concentration (MIC) value expressed in mg/mL).
Table 5. Antimicrobial activity of G. kurroo extracts (minimal inhibitory concentration (MIC) value expressed in mg/mL).
MicroorganismLeaf ExtractRoot ExtractStreptomycinSource
Proteus mirabilis0.27 ± 0.010.24 ± 0.040.055 ± 0.002[59]
Streptococcus faecalis0.29 ± 0.020.22 ± 0.040.025 ± 0.002
Escherichia coli0.75 ± 0.010.67 ± 0.060.055 ± 0.001
Salmonella enteritidis0.90 ± 0.020.75 ± 0.050.020 ± 0.003
Micrococcus luteus0.22 ± 0.080.15 ± 0.040.020 ± 0.004
Enterobacter cloacae0.60 ± 0.040.55 ± 0.030.015 ± 0.001
Each value is a mean of three biological replicas.
Table 6. The DPPH scavenging and superoxide scavenging activity determined by DPPH [82] and NBT assay [83].
Table 6. The DPPH scavenging and superoxide scavenging activity determined by DPPH [82] and NBT assay [83].
Extracts (600 μg/mL)DPPH Assay (%)NBT Assay (%)Source
Leaf5351[59]
Root7263
Control
Vitamin C/Ascorbic acid *9191.7
DPPH (1,1-Diphenyl-2-picrylhydrazyl) & NBT(nitroblue tetrazolium); * Ascorbic acid taken as a positive control.

Share and Cite

MDPI and ACS Style

Skinder, B.M.; Ganai, B.A.; Wani, A.H. Scientific Study of Gentiana kurroo Royle. Medicines 2017, 4, 74. https://doi.org/10.3390/medicines4040074

AMA Style

Skinder BM, Ganai BA, Wani AH. Scientific Study of Gentiana kurroo Royle. Medicines. 2017; 4(4):74. https://doi.org/10.3390/medicines4040074

Chicago/Turabian Style

Skinder, Bhat Mohd, Bashir Ahmad Ganai, and Abdul Hamid Wani. 2017. "Scientific Study of Gentiana kurroo Royle" Medicines 4, no. 4: 74. https://doi.org/10.3390/medicines4040074

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop